The steroid 17alpha-acetoxy-6-dimethylaminomethyl-21-fluoro-3-ethoxy-pregna-3, 5-dien-20-one (SC17599) is a selective mu-opioid agonist: implications for the mu-opioid pharmacophore

The steroid SC17599 (17alpha-acetoxy-6-dimethylaminomethyl-21-fluoro-3-ethoxypregna -3, 5-dien-20-one) has mu-opioid actions in vivo. The ability of SC17599 to interact with opioid receptors has been studied using radioligand and [(35)S]guanosine-5'-O-(3-thio)triphosphate (GTPgammaS) binding as...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular pharmacology 2000-10, Vol.58 (4), p.669-676
Hauptverfasser: McFadyen, I J, Houshyar, H, Liu-Chen, L Y, Woods, J H, Traynor, J R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 676
container_issue 4
container_start_page 669
container_title Molecular pharmacology
container_volume 58
creator McFadyen, I J
Houshyar, H
Liu-Chen, L Y
Woods, J H
Traynor, J R
description The steroid SC17599 (17alpha-acetoxy-6-dimethylaminomethyl-21-fluoro-3-ethoxypregna -3, 5-dien-20-one) has mu-opioid actions in vivo. The ability of SC17599 to interact with opioid receptors has been studied using radioligand and [(35)S]guanosine-5'-O-(3-thio)triphosphate (GTPgammaS) binding assays. SC17599 bound to mu-opioid receptors in SH-SY5Y neuroblastoma cells and to recombinant receptors expressed in rat C6 glioma cells and Chinese hamster ovary cells with good affinity and with greater than 100-fold selectivity for mu- over both delta- and kappa-opioid receptors. Binding was much reduced when aspartate 147 in the wild-type mu-opioid receptor was replaced with asparagine. The affinity of SC17599 for the mu-opioid receptor was decreased in the presence of sodium ions, indicating agonist activity. SC17599 stimulated the binding of [(35)S]GTPgammaS in a naloxone-reversible manner with good potency and maximal effect equivalent to that of the mu-opioid agonists fentanyl and [D-Ala(2),N-Me-Phe(4),Gly(5)-ol]-enkephalin. In rat brain membranes, SC17599-mediated stimulation of [(35)S]GTPgammaS binding was reversed by the antagonist naltrexone. SC17599 lacks an aromatic ring and para-hydroxyl substituent considered critical in the pharmacophore for mu-opioids. The structural relationship between SC17599 and more traditional opioid ligands was investigated through genetic algorithm-based modeling techniques for pharmacophore generation (GASP) and ligand-receptor docking (GOLD). The relatively planar and electron-rich A ring of the steroid compensated for the lack of aromaticity. Modeling of ligand-receptor docking showed that both morphine and SC17599 occupy the same binding pocket within the transmembrane helix bundle of the mu-opioid receptor and that the relationship between their binding modes largely mimicked the pharmacophore alignment.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_72284006</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72284006</sourcerecordid><originalsourceid>FETCH-LOGICAL-p545-f77c6a5f99f7dd2a1264b1aba33e1dc0c184c7e269cc74dfb803e659eba9361a3</originalsourceid><addsrcrecordid>eNpNkMtKxDAUhrtQnHH0FSQrUTCQS9M07mTwBoILZ-FuOE1Pp5G2qUkrzoP5fnaYETyb__DznQv_UTJnTGQ0N-p9lpzG-MEYT1XOTpIZZ2YqqebJz6pGEgcM3pWEa2j6GihYHPz3lma0dC0O9baB1nV-31LBadWMPngq6eTswD7gpgMqb4iaRrCjglHfIbl6W3KtjLkmLhIgERu0g_tC0o7U9253Eza-c3G4Ja7tG2dhcL6LpPKBDPV_bvortGB9X_uAZ8lxBU3E84MuktXD_Wr5RF9eH5-Xdy-0V6mildY2A1UZU-myFMBFlhYcCpASeWmZ5XlqNYrMWKvTsipyJjFTBgswMuMgF8nlfm0f_OeIcVi3LlpsGujQj3GthchTxrIJvDiAY9Fiue6DayFs1385y1-Ub3qC</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72284006</pqid></control><display><type>article</type><title>The steroid 17alpha-acetoxy-6-dimethylaminomethyl-21-fluoro-3-ethoxy-pregna-3, 5-dien-20-one (SC17599) is a selective mu-opioid agonist: implications for the mu-opioid pharmacophore</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Free Full-Text Journals in Chemistry</source><creator>McFadyen, I J ; Houshyar, H ; Liu-Chen, L Y ; Woods, J H ; Traynor, J R</creator><creatorcontrib>McFadyen, I J ; Houshyar, H ; Liu-Chen, L Y ; Woods, J H ; Traynor, J R</creatorcontrib><description>The steroid SC17599 (17alpha-acetoxy-6-dimethylaminomethyl-21-fluoro-3-ethoxypregna -3, 5-dien-20-one) has mu-opioid actions in vivo. The ability of SC17599 to interact with opioid receptors has been studied using radioligand and [(35)S]guanosine-5'-O-(3-thio)triphosphate (GTPgammaS) binding assays. SC17599 bound to mu-opioid receptors in SH-SY5Y neuroblastoma cells and to recombinant receptors expressed in rat C6 glioma cells and Chinese hamster ovary cells with good affinity and with greater than 100-fold selectivity for mu- over both delta- and kappa-opioid receptors. Binding was much reduced when aspartate 147 in the wild-type mu-opioid receptor was replaced with asparagine. The affinity of SC17599 for the mu-opioid receptor was decreased in the presence of sodium ions, indicating agonist activity. SC17599 stimulated the binding of [(35)S]GTPgammaS in a naloxone-reversible manner with good potency and maximal effect equivalent to that of the mu-opioid agonists fentanyl and [D-Ala(2),N-Me-Phe(4),Gly(5)-ol]-enkephalin. In rat brain membranes, SC17599-mediated stimulation of [(35)S]GTPgammaS binding was reversed by the antagonist naltrexone. SC17599 lacks an aromatic ring and para-hydroxyl substituent considered critical in the pharmacophore for mu-opioids. The structural relationship between SC17599 and more traditional opioid ligands was investigated through genetic algorithm-based modeling techniques for pharmacophore generation (GASP) and ligand-receptor docking (GOLD). The relatively planar and electron-rich A ring of the steroid compensated for the lack of aromaticity. Modeling of ligand-receptor docking showed that both morphine and SC17599 occupy the same binding pocket within the transmembrane helix bundle of the mu-opioid receptor and that the relationship between their binding modes largely mimicked the pharmacophore alignment.</description><identifier>ISSN: 0026-895X</identifier><identifier>PMID: 10999935</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Brain - drug effects ; Brain - metabolism ; Cell Line ; Cell Membrane - drug effects ; Cell Membrane - metabolism ; Guanosine 5'-O-(3-Thiotriphosphate) - metabolism ; Guinea Pigs ; Humans ; Male ; Models, Molecular ; Pregnadienes - pharmacology ; Radioligand Assay ; Rats ; Rats, Sprague-Dawley ; Receptors, Opioid, mu - agonists ; Tumor Cells, Cultured</subject><ispartof>Molecular pharmacology, 2000-10, Vol.58 (4), p.669-676</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10999935$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>McFadyen, I J</creatorcontrib><creatorcontrib>Houshyar, H</creatorcontrib><creatorcontrib>Liu-Chen, L Y</creatorcontrib><creatorcontrib>Woods, J H</creatorcontrib><creatorcontrib>Traynor, J R</creatorcontrib><title>The steroid 17alpha-acetoxy-6-dimethylaminomethyl-21-fluoro-3-ethoxy-pregna-3, 5-dien-20-one (SC17599) is a selective mu-opioid agonist: implications for the mu-opioid pharmacophore</title><title>Molecular pharmacology</title><addtitle>Mol Pharmacol</addtitle><description>The steroid SC17599 (17alpha-acetoxy-6-dimethylaminomethyl-21-fluoro-3-ethoxypregna -3, 5-dien-20-one) has mu-opioid actions in vivo. The ability of SC17599 to interact with opioid receptors has been studied using radioligand and [(35)S]guanosine-5'-O-(3-thio)triphosphate (GTPgammaS) binding assays. SC17599 bound to mu-opioid receptors in SH-SY5Y neuroblastoma cells and to recombinant receptors expressed in rat C6 glioma cells and Chinese hamster ovary cells with good affinity and with greater than 100-fold selectivity for mu- over both delta- and kappa-opioid receptors. Binding was much reduced when aspartate 147 in the wild-type mu-opioid receptor was replaced with asparagine. The affinity of SC17599 for the mu-opioid receptor was decreased in the presence of sodium ions, indicating agonist activity. SC17599 stimulated the binding of [(35)S]GTPgammaS in a naloxone-reversible manner with good potency and maximal effect equivalent to that of the mu-opioid agonists fentanyl and [D-Ala(2),N-Me-Phe(4),Gly(5)-ol]-enkephalin. In rat brain membranes, SC17599-mediated stimulation of [(35)S]GTPgammaS binding was reversed by the antagonist naltrexone. SC17599 lacks an aromatic ring and para-hydroxyl substituent considered critical in the pharmacophore for mu-opioids. The structural relationship between SC17599 and more traditional opioid ligands was investigated through genetic algorithm-based modeling techniques for pharmacophore generation (GASP) and ligand-receptor docking (GOLD). The relatively planar and electron-rich A ring of the steroid compensated for the lack of aromaticity. Modeling of ligand-receptor docking showed that both morphine and SC17599 occupy the same binding pocket within the transmembrane helix bundle of the mu-opioid receptor and that the relationship between their binding modes largely mimicked the pharmacophore alignment.</description><subject>Animals</subject><subject>Brain - drug effects</subject><subject>Brain - metabolism</subject><subject>Cell Line</subject><subject>Cell Membrane - drug effects</subject><subject>Cell Membrane - metabolism</subject><subject>Guanosine 5'-O-(3-Thiotriphosphate) - metabolism</subject><subject>Guinea Pigs</subject><subject>Humans</subject><subject>Male</subject><subject>Models, Molecular</subject><subject>Pregnadienes - pharmacology</subject><subject>Radioligand Assay</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptors, Opioid, mu - agonists</subject><subject>Tumor Cells, Cultured</subject><issn>0026-895X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkMtKxDAUhrtQnHH0FSQrUTCQS9M07mTwBoILZ-FuOE1Pp5G2qUkrzoP5fnaYETyb__DznQv_UTJnTGQ0N-p9lpzG-MEYT1XOTpIZZ2YqqebJz6pGEgcM3pWEa2j6GihYHPz3lma0dC0O9baB1nV-31LBadWMPngq6eTswD7gpgMqb4iaRrCjglHfIbl6W3KtjLkmLhIgERu0g_tC0o7U9253Eza-c3G4Ja7tG2dhcL6LpPKBDPV_bvortGB9X_uAZ8lxBU3E84MuktXD_Wr5RF9eH5-Xdy-0V6mildY2A1UZU-myFMBFlhYcCpASeWmZ5XlqNYrMWKvTsipyJjFTBgswMuMgF8nlfm0f_OeIcVi3LlpsGujQj3GthchTxrIJvDiAY9Fiue6DayFs1385y1-Ub3qC</recordid><startdate>200010</startdate><enddate>200010</enddate><creator>McFadyen, I J</creator><creator>Houshyar, H</creator><creator>Liu-Chen, L Y</creator><creator>Woods, J H</creator><creator>Traynor, J R</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200010</creationdate><title>The steroid 17alpha-acetoxy-6-dimethylaminomethyl-21-fluoro-3-ethoxy-pregna-3, 5-dien-20-one (SC17599) is a selective mu-opioid agonist: implications for the mu-opioid pharmacophore</title><author>McFadyen, I J ; Houshyar, H ; Liu-Chen, L Y ; Woods, J H ; Traynor, J R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p545-f77c6a5f99f7dd2a1264b1aba33e1dc0c184c7e269cc74dfb803e659eba9361a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Animals</topic><topic>Brain - drug effects</topic><topic>Brain - metabolism</topic><topic>Cell Line</topic><topic>Cell Membrane - drug effects</topic><topic>Cell Membrane - metabolism</topic><topic>Guanosine 5'-O-(3-Thiotriphosphate) - metabolism</topic><topic>Guinea Pigs</topic><topic>Humans</topic><topic>Male</topic><topic>Models, Molecular</topic><topic>Pregnadienes - pharmacology</topic><topic>Radioligand Assay</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptors, Opioid, mu - agonists</topic><topic>Tumor Cells, Cultured</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>McFadyen, I J</creatorcontrib><creatorcontrib>Houshyar, H</creatorcontrib><creatorcontrib>Liu-Chen, L Y</creatorcontrib><creatorcontrib>Woods, J H</creatorcontrib><creatorcontrib>Traynor, J R</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>McFadyen, I J</au><au>Houshyar, H</au><au>Liu-Chen, L Y</au><au>Woods, J H</au><au>Traynor, J R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The steroid 17alpha-acetoxy-6-dimethylaminomethyl-21-fluoro-3-ethoxy-pregna-3, 5-dien-20-one (SC17599) is a selective mu-opioid agonist: implications for the mu-opioid pharmacophore</atitle><jtitle>Molecular pharmacology</jtitle><addtitle>Mol Pharmacol</addtitle><date>2000-10</date><risdate>2000</risdate><volume>58</volume><issue>4</issue><spage>669</spage><epage>676</epage><pages>669-676</pages><issn>0026-895X</issn><abstract>The steroid SC17599 (17alpha-acetoxy-6-dimethylaminomethyl-21-fluoro-3-ethoxypregna -3, 5-dien-20-one) has mu-opioid actions in vivo. The ability of SC17599 to interact with opioid receptors has been studied using radioligand and [(35)S]guanosine-5'-O-(3-thio)triphosphate (GTPgammaS) binding assays. SC17599 bound to mu-opioid receptors in SH-SY5Y neuroblastoma cells and to recombinant receptors expressed in rat C6 glioma cells and Chinese hamster ovary cells with good affinity and with greater than 100-fold selectivity for mu- over both delta- and kappa-opioid receptors. Binding was much reduced when aspartate 147 in the wild-type mu-opioid receptor was replaced with asparagine. The affinity of SC17599 for the mu-opioid receptor was decreased in the presence of sodium ions, indicating agonist activity. SC17599 stimulated the binding of [(35)S]GTPgammaS in a naloxone-reversible manner with good potency and maximal effect equivalent to that of the mu-opioid agonists fentanyl and [D-Ala(2),N-Me-Phe(4),Gly(5)-ol]-enkephalin. In rat brain membranes, SC17599-mediated stimulation of [(35)S]GTPgammaS binding was reversed by the antagonist naltrexone. SC17599 lacks an aromatic ring and para-hydroxyl substituent considered critical in the pharmacophore for mu-opioids. The structural relationship between SC17599 and more traditional opioid ligands was investigated through genetic algorithm-based modeling techniques for pharmacophore generation (GASP) and ligand-receptor docking (GOLD). The relatively planar and electron-rich A ring of the steroid compensated for the lack of aromaticity. Modeling of ligand-receptor docking showed that both morphine and SC17599 occupy the same binding pocket within the transmembrane helix bundle of the mu-opioid receptor and that the relationship between their binding modes largely mimicked the pharmacophore alignment.</abstract><cop>United States</cop><pmid>10999935</pmid><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0026-895X
ispartof Molecular pharmacology, 2000-10, Vol.58 (4), p.669-676
issn 0026-895X
language eng
recordid cdi_proquest_miscellaneous_72284006
source MEDLINE; EZB-FREE-00999 freely available EZB journals; Free Full-Text Journals in Chemistry
subjects Animals
Brain - drug effects
Brain - metabolism
Cell Line
Cell Membrane - drug effects
Cell Membrane - metabolism
Guanosine 5'-O-(3-Thiotriphosphate) - metabolism
Guinea Pigs
Humans
Male
Models, Molecular
Pregnadienes - pharmacology
Radioligand Assay
Rats
Rats, Sprague-Dawley
Receptors, Opioid, mu - agonists
Tumor Cells, Cultured
title The steroid 17alpha-acetoxy-6-dimethylaminomethyl-21-fluoro-3-ethoxy-pregna-3, 5-dien-20-one (SC17599) is a selective mu-opioid agonist: implications for the mu-opioid pharmacophore
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T23%3A15%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20steroid%2017alpha-acetoxy-6-dimethylaminomethyl-21-fluoro-3-ethoxy-pregna-3,%205-dien-20-one%20(SC17599)%20is%20a%20selective%20mu-opioid%20agonist:%20implications%20for%20the%20mu-opioid%20pharmacophore&rft.jtitle=Molecular%20pharmacology&rft.au=McFadyen,%20I%20J&rft.date=2000-10&rft.volume=58&rft.issue=4&rft.spage=669&rft.epage=676&rft.pages=669-676&rft.issn=0026-895X&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E72284006%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72284006&rft_id=info:pmid/10999935&rfr_iscdi=true